4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-18-014142
Chief Technology Officer sold 7,000 shares at an average $27.61 ($193,303)
- Chief Technology Officer acquired 7,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myer Vickesh Chief Technology Officer | 2018-12-17 | Option exercise | +3,000 | $0.65 | $1,950 | 3,000 | D |
| Myer Vickesh Chief Technology Officer | 2018-12-17 | Sale | −2,300 | $27.75 | $63,825 | 700 | D |
| Myer Vickesh Chief Technology Officer | 2018-12-17 | Sale | −700 | $28.34 | $19,838 | 0 | D |
| Myer Vickesh Chief Technology Officer | 2018-12-18 | Option exercise | +4,000 | $11.21 | $44,840 | 4,000 | D |
| Myer Vickesh Chief Technology Officer | 2018-12-18 | Sale | −4,000 | $27.41 | $109,640 | 0 | D |
| Derivatives | |||||||
| Myer Vickesh Chief Technology Officer | 2018-12-17 | Option exercise · Stock Option (right to buy) | −3,000 | 82,307 | D | ||
| Myer Vickesh Chief Technology Officer | 2018-12-18 | Option exercise · Stock Option (right to buy) | −4,000 | 56,897 | D | ||
| Open-market sales · 7,000 sh · avg $27.61 · $193,303 | |||||||
Loading xslF345X03/edgar.xml…